A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Condition(s):Hematologic MalignancyLast Updated:November 14, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hematologic MalignancyLast Updated:November 14, 2023Completed
Condition(s):Multiple MyelomaLast Updated:February 14, 2007No longer available
Condition(s):Malignant Solid Tumor; Lymphomas; Multiple MyelomaLast Updated:January 27, 2014Completed
Condition(s):Non-Hodgkin’s Lymphoma (NHL); Multiple Myeloma; Waldenstrom’s Macroglobulinemia (WM); Other B-cell NHL Subtypes, Including WM; T-cell NHLLast Updated:July 18, 2018Completed
Condition(s):Multiple Myeloma; MyelomaLast Updated:July 10, 2023Active, not recruiting
Condition(s):NeoplasmsLast Updated:May 19, 2021Completed
Condition(s):Multiple MyelomaLast Updated:February 7, 2012Completed
Condition(s):Solid Tumors; Multiple Myeloma; Non-Hodgkins Lymphoma; Pancreatic Neuroendocrine Tumors; PNET; NHLLast Updated:December 15, 2017Terminated
Condition(s):Lymphoma; Multiple Myeloma; Acute Myeloid Leukemia; Diffuse Large B-Cell LymphomaLast Updated:December 22, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:April 27, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.